CVE Intelligence
Medium Cross-site scripting

CVE-2026-22913 — Cross-site Scripting (XSS) in SICK AG TDC-X401GL

Improper handling of a URL parameter may allow attackers to execute code in a user's browser after login. This can lead to the extraction of sensitive data.

Published Jan 15, 2026 · Updated Oct 13, 2026 · Sources: NIST National Vulnerability Database, CVE Program (cve.org) e CISA ADP · CNA: SICK AG

Who exploits it and how urgent it is

A 0–100 score combining confirmed exploitation, ransomware and APT use, public exploits, EPSS and severity.

No exploitation signal in the sources consulted so far.
How the score was calculated
  • EPSS 0.4% (30-day exploitation probability)+5
  • Technical severity (medium)+3

The score orders the patch queue; it does not replace your asset context (internet exposure, criticality, compensating controls).

Triage

Is it exploited, how likely is exploitation, what does it touch, and how severe do the sources call it.

Exploitation
Not confirmed
Not in CISA KEV — an absence of record, not proof it is unexploited.
EPSS FIRST
0.39%
ahead of 31% of scored CVEs · Oct 14, 2026
Affects
SICK AG
TDC-X401GL and 1 more
CVSS base
6.1
Medium · 3 source(s)

CISA SSVC assessment CISA

Three decision points CISA publishes for the CVEs it assesses (SSVC 2.0.3). A stakeholder decision, not a severity score.

Exploitation
None
none · proof-of-concept · active
Automatable
No
can an attacker script the kill-chain steps
Technical impact
Partial
partial · total control of the vulnerable component

Remediation

Fixes and mitigations documented by the sources — linked to the original advisory.

No fix documented by the sources we poll. That does not mean none exists: check the vendor advisory.

First 24 hours

Ordered from the record’s own fields — exposure first, because you cannot patch what you have not found. A rule-generated starting point.

  1. Identify exposed assets running the affected vendor/product/version combinations (SICK AG TDC-X401GL, SICK AG Tdc-x401gl Firmware).
  2. The attack is network-based and needs no privileges: restrict exposure (ACLs, VPN, WAF) until patched.
  3. No fix documented in the sources: reduce exposure and monitor the vendor advisory.
  4. Exploitation requires user interaction: tighten email/web filtering and warn affected users.
  5. Search available logs for exploit probes matching the vulnerability class (cross-site scripting), errors and authentication anomalies.

Affected scope

Vendor, product and versions as the sources word them.

VendorProductVersionsStatusSource
SICK AG TDC-X401GL < 1.5.0 Vulnerable CVE Program (cve.org) e CISA ADP
SICK AG Tdc-x401gl Firmware < 1.5.0 Vulnerable NIST National Vulnerability Database

Attack characteristics

The CVSS vector, decoded. It describes the attack, not your exposure to it.

Attack vector
Network
Attack complexity
Low
Privileges required
None
User interaction
Required
Scope
Changed
Confidentiality
Low
Integrity
Low
Availability
None

Every base score collected

Sources score independently and may disagree; each row says who scored it and under which version.

ScoreVersionSeverityExpl.ImpactScored by
6.1 CVSS 3.1 Medium 2.8 2.7 nvd@nist.gov via NIST National Vulnerability Database
4.3 CVSS 3.1 Medium 2.8 1.4 psirt@sick.de via NIST National Vulnerability Database
4.3 CVSS 3.1 Medium — — SICK AG via CVE Program (cve.org) e CISA ADP
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:N (score shown at the top: nvd@nist.gov)
Scoring entities (NIST, CNA, ADP) score independently; each score is shown with its origin. For prioritization we use 6.1 (NVD (NIST)) as a conservative provisional reference — not a definitive official score.

Weakness MITRE

Weakness class according to MITRE’s CWE catalog.

CWE-79 · Cross-site Scripting (XSS)

Other CVEs with this weakness →

EPSS over time FIRST

Oct 13, 2026 → Oct 14, 2026 · 2 reading(s) · max 0.39%

Detection

Read off the CVSS vector and the weakness class. Starting points, not tested rules.

  • Prioritize edge telemetry for the network-reachable component (proxy, WAF, IDS/IPS).
  • Monitor CSP violation reports and script payloads in reflected parameters.
web/proxy/WAF logsnetwork IDS/IPSapplication logs

Timeline

What happened to this CVE, newest first.

  • 2026
  • Affected products added · sick ag/tdc-x401gl
    Oct 13, 2026 · CVE Program (cve.org) e CISA ADP
  • SSVC assessment updated
    Oct 13, 2026 · CVE Program (cve.org) e CISA ADP
  • Record published
    Oct 13, 2026
  • CVSS changed · 6.1
    Oct 13, 2026 · NIST National Vulnerability Database
  • Source status changed · → Analyzed
    Oct 13, 2026 · NIST National Vulnerability Database
  • Record created in this database
    Oct 13, 2026 · NIST National Vulnerability Database
  • CVE published
    Jan 15, 2026 · SICK AG

Source activity

Repeated readings are counted rather than listed.

  • 1× Official description updated · Oct 13, 2026 – Oct 13, 2026

References

6 on the record

Elsewhere on this site

SICK AG
every CVE for this vendor
CWE-79
other pages naming this weakness

Related CVEs (same products)

  • Medium CVE-2026-22914 An attacker with limited permissions may still be able to write files to specific… Jan 15, 2026
  • Medium CVE-2026-22915 An attacker with low privileges may be able to read files from specific directories on… Jan 15, 2026
  • Medium CVE-2026-22916 An attacker with low privileges may be able to trigger critical system functions such as… Jan 15, 2026
  • High CVE-2026-22917 Allocation of Resources Without Limits or Throttling in SICK AG Tdc-x401gl Firmware Jan 15, 2026
  • High CVE-2026-22918 Clickjacking in SICK AG Tdc-x401gl Firmware Jan 15, 2026
  • Medium CVE-2026-22919 Cross-site Scripting (XSS) in SICK AG Tdc-x401gl Firmware Jan 15, 2026

Not in any source we poll

Listed rather than left blank: an empty field and an unmeasured one look identical on screen, and only one is a reason to look elsewhere.

  • No fixed version, patch or mitigation documented.
  • No confirmed IOCs, IP addresses, domains, file hashes, or malware artifacts supplied.
  • No organization-specific asset inventory, compensating-control status, or patch deployment evidence supplied.
  • No exploit packet captures, log samples, or incident case IDs supplied.

Answered from this record

Text assembled only from the fields above — no additional claims.

What should defenders know first?

CVE-2026-22913 is "Cross-site Scripting (XSS) in SICK AG TDC-X401GL", rated Medium. It affects TDC-X401GL (SICK AG); versions are in the scope table. It is not in CISA KEV, which does not rule out exploitation. CVSS 6.1 describes technical severity. EPSS 0.39% estimates the probability of exploitation in 30 days; neither replaces your asset context. First verify whether exposed or business-critical assets run the affected versions, apply vendor fixes or mitigations, and preserve logs for review.

Comments

Moderated technical discussion. Read the community guidelines.

No comments yet.

Sign in or create an account to comment and suggest corrections.